Source:http://linkedlifedata.com/resource/pubmed/id/12519588
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-1-9
|
pubmed:abstractText |
Granulopoiesis-stimulating factors (G-CSF and GM-CSF) are being used to prevent febrile neutropenia and infections in the treatment of patients with malignant lymphoma. The question whether G-CSF and GM-CSF improve dose-intensity, tumour response and overall survival in this patient population has not been answered yet. Since the results from single studies are inconclusive a systematic review was required.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD003189
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12519588-Antineoplastic Agents,
pubmed-meshheading:12519588-Fever,
pubmed-meshheading:12519588-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:12519588-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:12519588-Humans,
pubmed-meshheading:12519588-Lymphoma,
pubmed-meshheading:12519588-Neutropenia,
pubmed-meshheading:12519588-Randomized Controlled Trials as Topic
|
pubmed:year |
2002
|
pubmed:articleTitle |
Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma.
|
pubmed:affiliation |
Department I of Internal Medicine, University of Cologne, Kerpener Str. 15, Cologne, Germany, 50924. julia.bohlius@medizin.uni-koeln.de
|
pubmed:publicationType |
Journal Article,
Review
|